Cookies help us to understand how you use our website so that we can provide you with the best experience when you are on our site. To find out more, read our privacy policy and cookie policy.
Manage Cookies
A cookie is information stored on your computer by a website you visit. Cookies often store your settings for a website, such as your preferred language or location. This allows the site to present you with information customized to fit your needs. As per the GDPR law, companies need to get your explicit approval to collect your data. Some of these cookies are ‘strictly necessary’ to provide the basic functions of the website and can not be turned off, while others if present, have the option of being turned off. Learn more about our Privacy and Cookie policies. These can be managed also from our cookie policy page.
Strictly necessary cookies(always on):
Necessary for enabling core functionality. The website cannot function properly without these cookies. This cannot be turned off. e.g. Sign in, Language
Analytics cookies:
Analytical cookies help us to analyse user behaviour, mainly to see if the users are able to find and act on things that they are looking for. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. Tools used: Google Analytics
Social media cookies:
We use social media cookies from Facebook, Twitter and Google to run Widgets, Embed Videos, Posts, Comments and to fetch profile information.
Can you help us to design a clinical trial to improve radiotherapy treatment for people with breast cancer?
Share Can you help us to design a clinical trial to improve radiotherapy treatment for people with breast cancer? on FacebookShare Can you help us to design a clinical trial to improve radiotherapy treatment for people with breast cancer? on TwitterShare Can you help us to design a clinical trial to improve radiotherapy treatment for people with breast cancer? on LinkedinEmail Can you help us to design a clinical trial to improve radiotherapy treatment for people with breast cancer? link
Consultation has concluded
We would like to talk to people who have had a diagnosis of breast cancer within the last 10-15 years and have had radiotherapy treatment. We would like you to contribute your thoughts and opinions about the design of a research trial.
A UK radiotherapy research trial (FAST-Forward) has already shown that standard radiotherapy treatment for breast cancer can be delivered as safely and effectively in 1 week as treatment given in 3 weeks. People with a slightly higher risk of cancer returning (for example those 50 years and under, and/or those with higher grade cancers), are given an extra dose or “boost dose” of radiotherapy during their treatment and this is usually given over three or four weeks.
We are designing a clinical trial (FAST-Forward Boost) to test whether patients having radiotherapy to the breast including a boost dose can be safely and effectively treated in one week rather than three to four weeks.
We want to understand patients’ perspectives on this research to make sure the clinical trial is patient centred. Radiotherapy treatment needs people to attend hospital every day for treatment so we would really like to hear from people from all types of different backgrounds, different cultures, those who find it difficult to travel to hospital and have caring/work responsibilities.
Our planned online Focus Groups will be held on:
Wednesday 9th August at 15.00 - 16.00
Thursday 10th August 16.00 - 17.00
If you would like some more information or are interested in helping to shape this research project by attending one of the focus groups, please contact us by emailing [email protected] by the end of day on the 8th August.
We would like to talk to people who have had a diagnosis of breast cancer within the last 10-15 years and have had radiotherapy treatment. We would like you to contribute your thoughts and opinions about the design of a research trial.
A UK radiotherapy research trial (FAST-Forward) has already shown that standard radiotherapy treatment for breast cancer can be delivered as safely and effectively in 1 week as treatment given in 3 weeks. People with a slightly higher risk of cancer returning (for example those 50 years and under, and/or those with higher grade cancers), are given an extra dose or “boost dose” of radiotherapy during their treatment and this is usually given over three or four weeks.
We are designing a clinical trial (FAST-Forward Boost) to test whether patients having radiotherapy to the breast including a boost dose can be safely and effectively treated in one week rather than three to four weeks.
We want to understand patients’ perspectives on this research to make sure the clinical trial is patient centred. Radiotherapy treatment needs people to attend hospital every day for treatment so we would really like to hear from people from all types of different backgrounds, different cultures, those who find it difficult to travel to hospital and have caring/work responsibilities.
Our planned online Focus Groups will be held on:
Wednesday 9th August at 15.00 - 16.00
Thursday 10th August 16.00 - 17.00
If you would like some more information or are interested in helping to shape this research project by attending one of the focus groups, please contact us by emailing [email protected] by the end of day on the 8th August.
